What is Altimmune's total liabilities?

Altimmune (ALT) reported total liabilities of $51.64M in Q1 2026.

How has Altimmune's total liabilities changed year-over-year?

Altimmune's total liabilities increased by 242.0% year-over-year, from $15.1M to $51.64M.

What is the long-term trend for Altimmune's total liabilities?

Over 5 years (2020 to 2025), Altimmune's total liabilities has grown at a 23.4% compound annual growth rate (CAGR), from $19.24M to $55.04M.

What does total liabilities mean?

The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.

Altimmune ALT Total Liabilities

Total Liabilities at other companies

Merck & Co.MRK

$229M—

Madrigal Pharmaceuticals, Inc.MDGL

$683.87M+139%

Viking TherapeuticsVKTX

$106.33M+430%

Wave Life SciencesWVE

$71.81M-33.9%

Delcath SystemsDCTH

$845K-24.1%

MeiraGTx Holdings plcMGTX

$302.79M+58.6%

Other financials

Income statement

See full

Revenue$26.0K+420%

Operating income-$24.2M-11.1%

Net income-$22.6M-15.3%

EPS (diluted)-$0.18+30.8%

Balance sheet

See full

Cash & equivalents$97.6M+98.7%

Total debt$34.8M+14,092%

Total equity$284.0M+99.8%

Total assets$335.6M+113%

Cash flow

See full

Operating cash flow-$20.9M-24.4%

CapEx$21.0K—

Free cash flow-$21.0M—

Valuation

See full

Market cap$558.14M-2.1%

Enterprise value$495.27M-5.0%

P/S13,613.2×-24,380×

Profitability

See full

Operating margin-230,461%-82,087pp

Net margin-214,861%-76,057pp

FCF margin-17,806.8%-110,030pp

Returns & leverage

See full

Return on equity-42.7%-8.7pp

Debt / equity0.1×+0.1×

Current ratio29.6×+13.7×

Where this comes from

Reported directly by Altimmune in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Altimmune's total liabilities?: Altimmune (ALT) reported total liabilities of $51.64M in Q1 2026.
How has Altimmune's total liabilities changed year-over-year?: Altimmune's total liabilities increased by 242.0% year-over-year, from $15.1M to $51.64M.
What is the long-term trend for Altimmune's total liabilities?: Over 5 years (2020 to 2025), Altimmune's total liabilities has grown at a 23.4% compound annual growth rate (CAGR), from $19.24M to $55.04M.
What does total liabilities mean?: The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.